- Home
- BCRX vs AMC Comparison
BCRX vs AMC Comparison
Compare BCRX & AMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- AMC
- Stock Information
- Founded
- BCRX 1986
- AMC 1920
- Country
- BCRX United States
- AMC United States
- Employees
- BCRX N/A
- AMC N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- AMC Movies/Entertainment
- Sector
- BCRX Health Care
- AMC Consumer Discretionary
- Exchange
- BCRX Nasdaq
- AMC Nasdaq
- Market Cap
- BCRX 1.7B
- AMC 1.6B
- IPO Year
- BCRX 1994
- AMC 2013
- Fundamental
- Price
- BCRX $7.03
- AMC $4.48
- Analyst Decision
- BCRX Buy
- AMC Sell
- Analyst Count
- BCRX 6
- AMC 5
- Target Price
- BCRX $14.67
- AMC $4.30
- AVG Volume (30 Days)
- BCRX 2.5M
- AMC 10.6M
- Earning Date
- BCRX 11-04-2024
- AMC 11-06-2024
- Dividend Yield
- BCRX N/A
- AMC N/A
- EPS Growth
- BCRX N/A
- AMC N/A
- EPS
- BCRX N/A
- AMC N/A
- Revenue
- BCRX $412,579,000.00
- AMC $4,435,200,000.00
- Revenue This Year
- BCRX $37.24
- AMC N/A
- Revenue Next Year
- BCRX $19.30
- AMC $10.40
- P/E Ratio
- BCRX N/A
- AMC N/A
- Revenue Growth
- BCRX 29.92
- AMC N/A
- 52 Week Low
- BCRX $4.03
- AMC $2.38
- 52 Week High
- BCRX $8.88
- AMC $11.88
- Technical
- Relative Strength Index (RSI)
- BCRX 40.38
- AMC 51.58
- Support Level
- BCRX $6.85
- AMC $4.17
- Resistance Level
- BCRX $8.25
- AMC $4.87
- Average True Range (ATR)
- BCRX 0.46
- AMC 0.24
- MACD
- BCRX -0.08
- AMC 0.02
- Stochastic Oscillator
- BCRX 11.32
- AMC 44.29
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About AMC AMC Entertainment Holdings Inc.
AMC Entertainment Holdings Inc is involved in the theatrical exhibition business. It owns, operates or has interests in theatres located in the United States and Europe. It provides amenities such as plush, power recliners, MacGuffins full bars, AMC Dine-In Theatres, premium presentation. The Company has identified two reportable segments and reporting units for its theatrical exhibition operations, U.S. markets and International markets. It derives key revenue from the U.S.